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Attempts to improve the selectivity of anti-cancer chemotherapy
have led to the development of treatments which target anti-
tumour agents to the tumour. One of the most recent developments
in targeted therapy is Antibody Directed Enzyme Prodrug Therapy
(ADEPT) (Bagshawe, 1987). ADEPT utilizes a monoclonal anti-
body raised against a tumour-associated antigen, linked to an
enzyme, which cleaves a relatively inactive prodrug into a highly
diffusable cytotoxic species within the tumour, killing both antigen
positive and negative neoplastic cells. 
ZD2767 is the latest ADEPT system to be developed and has
recently completed a Phase 1 clinical evaluation in patients with
carcinoembryonic antigen (CEA)-expressing tumours. The ZD2767
ADEPT system utilizes the A5B7 F(ab′ )2-carboxypeptidase G2
(CPG2) conjugate (ZD2767C) which is targeted at CEA expressing
tumours. The enzyme specifically activates a di-iodophenol mus-
tard glutamate prodrug (4-[N,N-bis(2-iodoethyl)amino]phenoxy-
carbonyl L-glutamic acid, ZD2767P, Figure 1A) to the potent di-
iodophenol mustard (4-[N,N-bis(2-iodoethyl)amino]phenol, ZD2767D,
Figure 1B), via the cleavage of the carbamate bond releasing the
glutamate moiety (Springer et al, 1995; Blakey et al, 1996). 
Previous investigations have demonstrated that ZD2767P +
CPG2 is both cytotoxic and growth inhibitory in human colorectal
and NSCLC tumour cell lines (Monks et al, submitted).
Comparisons of ZD2767P + CPG2 with the classical aniline
mustard chlorambucil have identified similar patterns of activity in
both types of tumour cell lines; however, ZD2767P + CPG2 was at
least 100-fold more potent than chlorambucil. ZD2767P + CPG2
rapidly forms DNA-DNA interstrand cross-links in a concentra-
tion-dependent manner, the lesion thought to be responsible for
the cytotoxicity of bifunctional agents such as chlorambucil,
melphalan and HN2. 
The mechanism underlying ZD2767P + CPG2-induced cell
death has not been determined, although it has been stated that
‘almost without exception toxins induce death by apoptosis’
(Hickman and Boyle, 1997). The structurally and chemically
related aniline mustard chlorambucil has been reported to induce
apoptosis in B-cell chronic lymphocytic leukaemia (B-CLL) cells
both in vivo (Begleiter et al, 1994) and in vitro (Pepper et al,
1997), in a concentration-dependent manner. Studies in HL-60
human promyelocytic leukaemia cells also demonstrated that
chlorambucil (3 mM) induces apoptosis; however, increasing the
concentration to 30 mM produced cell death by necrosis (Lennon
et al, 1991). 
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Summary ZD2767P is a phenol mustard glutamate prodrug which is currently being developed for Antibody Directed Enzyme Prodrug
Therapy (ADEPT). In ZD2767 ADEPT an active bi-functional alkylating drug, ZD2767D (4-[N,N-bis(2-iodoethyl)amino]phenol), is generated
following cleavage of ZD2767P by the bacterial enzyme carboxypeptidase G2 (CPG2) which is targeted to the tumour by conjugation to the
F(ab′ )2 fragment of the anti-CEA antibody A5B7. The aim of the studies described here was to identify the mode of cell death induced by
ZD2767P + CPG2 in comparison to the established nitrogen mustard chlorambucil. The contribution of bifunctional and monofunctional
ZD2767 DNA lesions to cell death induction was investigated using a monofunctional ZD2767D analogue. Apoptosis in LoVo tumour cells
was studied by three different methods (nuclear morphology, annexin V staining and TUNEL). Levels of apoptosis detected using the three
assays were similar, and each drug treatment produced apoptosis at levels above those in control cells at concentrations which resulted in
tumour cell growth inhibition. The bi-functional compounds, ZD2767P + CPG2 and chlorambucil, induced apoptosis in a concentration and
time dependent manner, with equitoxic concentrations producing equivalent levels of apoptosis. In contrast, the mono-functional ZD2767D
analogue at 100 µ M resulted in the maximal level of apoptosis at 25 h with no further increase over the following 72 h. These studies have
demonstrated that apoptosis is the mechanism of cell death induced by the ZD2767 ADEPT system, and that levels of apoptosis produced
by ZD2767 are similar to those observed at equitoxic concentrations of the classical nitrogen mustard chlorambucil. The mono-functional
ZD2767 analogue also induced apoptosis, but with a different time course and characteristics. In conjunction with previous data, these studies
have shown that the potent activity of ZD2767 can be attributed to the ability of the compound to induce bifunctional DNA lesions and engage
apoptosis. © 2001 Cancer Research Campaign http://www.bjcancer.com
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The investigations presented here were undertaken to determine
the mode of cell death induced by treatment with ZD2767P +
CPG2. LoVo colorectal tumour cells were chosen for these studies
as they are sensitive to, and have been extensively used in in vitro
and in vivo studies with, the ZD2767 ADEPT system (Blakey et al,
1996; Springer et al, 1995). Apoptosis was determined using 3
distinct methods which assess apoptosis-related morphological
changes. Firstly, apoptotic nuclear morphology was assessed
by staining cells with Hoechst 33258, a bis(benzimidazole) 
dye which becomes highly fluorescent when bound to A-T rich
sequences of double-stranded DNA allowing the assessment of
chromatin structure by fluorescent microscopy (Lootiens et al,
1990). In addition, two flow cytometric assays were also used to
measure apoptosis, each directed at different phenomena which
arise during apoptotic cell death. The annexin V-propidium iodide
dual staining assay (Vermes et al, 1995) was used to detect the loss
of plasma membrane phospholipid asymmetry, which results in
phosphatidylserine being exposed on the surface of the cell. Loss
of membrane asymmetry occurs early in apoptosis (Fadok et al,
1992) and precedes the loss of membrane selective permeability
(detected by the exclusion of PI) and other events normally associ-
ated with apoptosis such as chromatin condensation (Martin et al,
1995). The second flow cytometric method used was the terminal
deoxynucleotidyl transferase-mediated dUTP nick end labelling
(TUNEL) assay which measures the extent of DNA fragmentation,
an event which occurs once specific DNA endonucleases have
been activated (Gavrieli et al, 1992; Sgonc et al, 1994). 
The aim of the studies described here was to determine the
mechanism, time course and level of cell death induced by
ZD2767P + CPG2 in LoVo colorectal tumour cells as assessed by
three distinct morphological features of apoptosis. In addition, the
importance of mono- and bi-functional lesions to drug-induced cell
death was studied by comparing ZD2767P + CPG2-induced apop-
tosis with that induced by the bifunctional aniline mustard chlo-
rambucil (Figure 1D) and a structurally related monofunctional
ZD2767D analogue (Figure 1C). With a targeted therapy such as
ADEPT, it could be argued that the mechanism of cell killing is not
relevant to the ultimate anti-tumour effect, provided the tumour
cell is effectively targeted and killed. However, there is increasing
evidence that an inability to engage apoptosis can represent a resis-
tance mechanism to cytotoxic drugs, and many of the signal trans-
duction pathways required for apoptotic cell death have been
defined (Hickman and Boyle, 1997). Conversely, local inflamma-
tory responses could be an important determinant of tumour
response following cell death by necrosis. Hence an understanding
of the mechanism of cell killing following ADEPT therapy could
ultimately be of value in selecting tumours and patients who are
more likely to respond to treatment by virtue of the presence of
factors required for the relevant mechanism of cell death. 
MATERIALS AND METHODS 
Materials 
The prodrug ZD2767P was synthesized as described previously
(Springer et al, 1995), as was the monofuntional ZD2767D
analogue (Monks et al, submitted). Chlorambucil was purchased
from Sigma Chemical Co. (Poole, Dorset, UK) and CPG2 was
provided by CAMR (Salisbury, Wiltshire, UK). The LoVo
colorectal tumour cell line was obtained from the European
Collection of Animal Cell Cultures (ECACC, Wiltshire, UK). All
cell lines were maintained in RPMI 1640 (complete) medium
containing 2 mM L-glutamine (Gibco-BRL Life Technologies
Ltd, Paisley, UK), supplemented with 10% (v/v) FCS
(Globerpharm Ltd, Esher, Surrey, UK) and incubated at 37˚C, 5%
CO2. The LoVo cells were routinely tested to exclude mycoplasma
infection (Chen, 1977). All other reagents were supplied by Sigma
Chemical Co., (Poole, Dorset, UK), unless stated otherwise. 
Drug treatment and cell growth inhibition 
On day 0, exponential growing LoVo colorectal tumour cells were
harvested, and 2 × 105 cells seeded in 10 ml of medium. On day 3,
the medium was removed from each flask and replaced with fresh
medium, with the exception of cells treated with ZD2767P which
received medium containing 1 unit/ml of CPG2. Each compound
was prepared from solid immediately prior to each experiment, by
serial dilution in DMSO to 100 × the final required concentration.
The cells were exposed to each drug for 1 h, with control cells
being exposed to a similar concentration of DMSO alone (1% v/v).
Following the drug exposure, the medium was removed and
replaced with 10 ml of fresh drug-free medium. One flask treated
with each drug concentration and a control flask were taken 1 h
after the end of the drug exposure, and at 24-hour intervals there-
after, and the level of apoptosis assessed using the three assays. All
three drug treatments (ZD2767P + CPG2, chlorambucil and the
monofunctional ZD2767D analogue) were studied concurrently in
each experiment in order to allow the direct comparison of results. 
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Figure 1 Structure of the compounds investigated. (A) 4-[N,N-bis 
(2-iodoethyl)amino]phenoxycarbonyl L-glutamic acid prodrug (ZD2767P), 
(B) 4-[N,N-bis(2-iodoethyl)amino]phenol drug (ZD2767D), (C) 4-[N-
(iodoethyl)-N-ethyl-amino]phenol drug (monofunctional ZD2767D) and 
(D) 4-[p-bis(2-chloroethyl)aminophenyl]butyric acid (chlorambucil) 
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To determine drug-induced growth inhibition, cells were seeded
at a density of 2 × 104 cells/ml on day 0. On day 3 the medium was
removed and replaced with of fresh medium, with the exception of
the ZD2767P + CPG2-treated cells where the medium contained
1 unit/ml of CPG2. One unit of CPG2 is defined as the amount of
enzyme required to hydrolyse 1 µ mol of methotrexate per min per
ml of reaction mixture at 37˚C (Sherwood et al, 1985). Each drug
concentration (100 × final concentration in DMSO) was added to
the cells, resulting in the same concentrations as those used in the
apoptosis studies. The cells were exposed to each compound for 1
h, after which the medium was removed and replaced with fresh
drug-free medium. Both the adherent cells and those in suspension
were pooled and the cell number was measured at 1, 25, 49, 73 and
97 hours using a model Z1 Coulter Counter (Coulter Electronics,
Bedfordshire, UK). 
Measurement of apoptosis by Hoechst 33258 nuclear
morphology staining 
After drug exposure and post-exposure incubation for the time
indicated, the medium in which the cells were being cultured was
removed and put aside. The cells were harvested using trypsin
(Gibco-BRL Life Technologies Ltd) in Dulbecco’s PBS containing
0.054 mM EDTA. Once released from the tissue culture plastic,
the cells were returned to the original medium in which they had
been cultured, and disagregated by pipetteing the suspension up
and down 6–7 times in a 5 ml pipette, following which they were
centrifuged at 300 × g for 5 min. The supernatant was removed and
the cell pellet re-suspended in 10 ml of ice cold PBS. One ml of
each sample was transferred to an eppendorf tube, and then
centrifuged at 300 × g for 5 min at room temperature, following
which the supernatant was removed and the cells fixed by resus-
pending the pellet in 20 µ l of Carnoy’s fixative (methanol:glacial
acetic acid, 3:1 v/v) for 1 minute. After fixation, 20 µ l of Hoechst
33258 (8 µ g/ml in Dulbecco’s PBS) was added to the cells and
samples incubated in the dark for 5 min. The samples were subse-
quently mixed and 20 µ l placed onto a glass slide under a cover
slip. A fluorescent microscope (Zeiss, Heidleberg, Germany) fitted
with an HBO 50 W high pressure mercury lamp (Osram,
Germany) was used to count approximately 600 nuclei/slide, from
which the percentage of apoptotic nuclei (condensed chromatin)
was calculated. 
Measurement of apoptosis by Annexin V – Propidium
iodide dual staining 
LoVo colorectal cells were treated and harvested in ice cold PBS as
described above. Each sample was centrifuged again at 300 × g for
5 min, following which the supernatant was removed and the cells
re-suspended at a density of approximately 1 × 106 cells/ml in
binding buffer (HEPES buffered saline solution supplemented
with 2.5 mM CaCl2). 100 µ l of cell suspension (approximately 1 ×
105 cells) was then placed in an eppendorf tube to which 10 µ l of
FITC-labelled annexin V (AnV) (10 µ g/ml) and 10 µ l of pro-
pidium iodide (PI) (50 µ g/ml) were added and mixed gently. The
following four control samples were also produced in order to cali-
brate the flow cytometer: untreated control cells without AnV or PI
stains, untreated control cells with only AnV stain; untreated
control cells with only PI stain, and untreated control cells with
both AnV and PI stains. The samples were then incubated for
15 min at room temperature in the dark, after which an additional
400 µ l of binding buffer was added to each sample. The level of
apoptosis was analysed using a FACScan flow cytometer, (Becton
Dickinson, Oxford, UK) within 1 h of staining. 
The flow cytometric analysis was performed according to manu-
facturer’s instructions (Apoptosis Detection Kit, R&D Systems,
Abingdon, UK). Accurate analysis of annexin V-PI labeled cells
requires electronic compensation to exclude any overlap between
the FITC and PI emission spectra. Compensation is achieved by
setting the instrument using singly-stained control samples at the
beginning of each analysis to adjust for any spectral overlap.
Apoptotic cells were defined as those that were AV +ve/PI–ve,
cells which did not stain for either AnV or PI were considered to
be viable and non-apoptotic, and late apoptotic/ necrotic cells were
those which were AnV +ve and PI +ve. 
Measurement of apoptosis by terminal
deoxynucleotidyl transferase-mediated dUTP nick end
labelling (TUNEL) 
Following treatment, cells were harvested as described above and
resuspended in ice cold PBS at a density of approximately 1 × 107
cells/ml. 100 µ l of the cell suspension (≈ 1 × 106 cells) was trans-
ferred to an eppendorf tube and fixed for 30 min in 100 µ l
paraformaldehyde (4% w/v in PBS, pH 7.4, prepared prior to each
assay) with regular mixing to avoid cell clumping. After fixation
the cells were washed in 1 ml of ice cold PBS and centrifuged at
300 × g for 8 min at room temperature. The supernatant was subse-
quently removed and the pellet re-suspended in 100 µ l permeabi-
lizing solution (0.1% (w/v) Triton® X-100, in 0.1% (w/v) sodium
citrate in de-ionized water) and kept on ice for 2 min. The samples
were then washed in 1 ml of ice cold PBS followed by centrifuga-
tion at 300 × g for 8 min at room temperature, after which 35 µ l of
TUNEL reaction mixture (enzyme solution; terminal deoxy-
nucleotidyl transferase from calf thymus, plus label solution;
nucleotide mixture in reaction buffer containing FITC-dUTP. In
Situ Cell Death Detection Kit, Boehringer Mannheim, Lewes, UK)
was added to each sample. Prior to mixing the label solution with
the enzyme, 100 µ l of label solution was set aside to use as a
control in the calibration of the flow cytometer. Three controls
were used routinely during the assay, a blank (untreated cells in
PBS only), a label control (untreated cells with only label solution)
and a negative control (untreated cells with the TUNEL reaction
mixture). A positive control, untreated cells incubated with 100 µ l
of DNAase 1 solution (100 µ g/ml DNAase 1 in 30 mM Trizma
base, 4 mM MgCl2, 0.1 mM dithiothreitol, pH 7.2) for 10 min at
room temperature, followed by treatment with TUNEL reaction
mixture was also used. 
The samples were incubated with the TUNEL reaction mixture
for 1 h 37˚C in a humidified atmosphere, after which they were
washed with 1 ml of ice cold PBS and centrifuged at 300 × g for
8 min at room temperature. The cell pellet was then re-suspended
in 400 µ l of PBS, and fluorescence analysed using a FACScan
flow cytometer (Becton Dickinson, Oxford, UK). Analysis of
TUNEL stained samples involves comparison with an untreated
control. The negative control cell population were gated at the
upper end of the histogram, with approximately 1–5% of the cells
being present within the gate, and this fraction of cells was consid-
ered apoptotic. Treated samples were then analysed and the same
gate was applied, and any increase in the level of DNA breaks was
detected as an increase in FITC-dUTP incorporated into the DNA,
and visualized as an increase in the percentage of cells in the gated
region. 
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RESULTS 
Growth inhibition studies 
To establish the relationship between growth inhibition and
apoptosis, LoVo cell number was determined at that same drug
concentrations and time points (1, 25, 49, 73 and 97 h) that apop-
tosis was investigated (Figure 2). ZD2767P + CPG2 caused a
concentration-dependent decrease in the growth of LoVo
colorectal tumour cells, with 1 and 10 µ M producing cytostasis
whereas 0.01 and 0.1 µ M produced only limited growth inhibi-
tion. In the case of chlorambucil only the 1000 µ M concentration
resulted in complete growth inhibition. Slight growth inhibition
was observed following exposure to 100 µ M, whilst 1 and 10 µ M
chlorambucil resulted in growth similar to that of the control
cells. Following exposure to the monofunctional ZD2767D
analogue, complete growth inhibition was seen with cells treated
with 100 and 1000 µ M, whereas cell growth was not inhibited 
by either 1 or 10 µ M monofunctional ZD2767D analogue. In
previous studies (Monks et al, submitted) using the same assay
conditions, the GI50 values for ZD2767P + CPG2, chlorambucil
and monofunctional ZD2767D were 0.41 ± 0.14 µ M, 79 ± 5 µ M
and 18 ± 5 µ M, respectively, values consistent with the results
presented here. 
Induction of apoptosis by ZD2767P + CPG2 
To determine the mode, time course and concentration
dependency of cell death induced by ZD2767P + CPG2, LoVo
colorectal tumour cells were treated with four concentrations of
ZD2767P + CPG2. LoVo cells were exposed to ZD2767P +
CPG2 for 1 h prior to analysis of the levels of apoptosis 1, 25, 49,
73, and 97 hours after the exposure. Cell death detected by the
three methods was concordant with respect to both the level and
time course of apoptosis (Figure 3). In all three assays ZD2767P
+ CPG2-induced apoptosis was only seen following treatment
with 1 and 10 µ M drug; concentrations that produced cell growth
inhibition (Figure 2). The levels of apoptosis detected at 0.01 and
0.1 µ M did not differ from control levels as assessed by any of
the three assays over the 97-hour experimental period. 
Regardless of the assay used, drug-induced apoptosis was not
detected 1 h after the end of the drug exposure. However, levels of
apoptosis induced by both the 1 and 10 µ M ZD2767P + CPG2
concentrations were above those seen in the control cells by 25 h
and increased thereafter with time. 
Overall, these data demonstrate that cytostasis produced
by ZD2767P + CPG2 is associated with the induction of apop-
tosis which is detectable 25 h after the end of the 1-hour drug
exposure, and increases thereafter with time. The use of three
independent methods of measuring apoptosis, which all gave
similar results, allows confidence to be placed in the results
obtained. 
Induction of apoptosis by chlorambucil 
To investigate whether the induction of apoptosis by ZD2767P +
CPG2 is similar to that produced by a classical aniline mustard,
LoVo colorectal tumour cells were exposed for 1 h to increasing
concentrations of chlorambucil. As with ZD2767P + CPG2, chlo-
rambucil produced apoptosis in a concentration-dependent manner
(Figure 4). Again the data from the three apoptosis assays were in
agreement, and demonstrated that levels of apoptosis were only
greater than in control cells following treatment with 1000 µ M
chlorambucil. The level of apoptosis again increased with time
following the 1-hour exposure, as illustrated most clearly by the
data from the TUNEL assay (Figure 4C). 
The results generated using chlorambucil show that induction of
apoptosis is drug concentration-dependent, and that significant
levels of apoptosis are associated with total growth inhibition.
Furthermore, both the time course and level of apoptosis induced
by chlorambucil were very similar to those produced by equitoxic
concentrations of ZD2767P + CPG2. 
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Figure 2 Growth inhibition of LoVo colorectal tumour cells treated with
ZD2767P + CPG2, chlorambucil or monofunctional ZD2767 analogue. Total
cell number was determined after treatment with (A) ZD2767P + 1 unit/ml
CPG2, (B) chlorambucil and (C) mono-functional ZD2767 analogue. The
results are expressed as the fold increase in cell number over the 1 h control
cell number. Each point represents the mean ± s.d. of n = 3 experiments
performed as described in Materials and Methods 
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Induction of apoptosis by the monofunctional ZD2767D
analogue 
Previously, it has been shown that the level and pattern of sensitivity
of a panel colorectal tumour cell lines to the monofunctional
ZD2767D analogue is distinct from that of ZD2767P + CPG2 or
chlorambucil (Monks et al, submitted). Furthermore, the monofunc-
tional ZD2767D analogue produced different DNA lesions, primarily
DNA strand breaks, compared to the bifunctional agents ZD2767P +
CPG2 and chlorambucil, which produced DNA-DNA interstrand
cross-links. To establish whether the differences in the cellular effects
of the monofunctional and bifunctional drugs extended to the mecha-
nism of cell death, the level and time course of apoptosis induced 
by the monofunctional ZD2767D analogue was determined and
compared to data for ZD2767P + CPG2 and chlorambucil. 
As observed with the lower concentrations of the bifunctional
agents, no apoptosis or growth inhibition was detected at the 
1 or 10 µ M monofunctional ZD2767D analogue (Figure 5 and
Figure 2C, respectively). However, both the Hoechst 33258 DNA
morphology staining and Annexin V-PI dual staining assays
demonstrated that 100 µ M monofunctional ZD2767D analogue
induced apoptosis, with maximum levels being reached by 25 h
(16% and 22 %, respectively). In contrast, using the TUNEL assay,
maximum levels of apoptosis (18%) were not reached until 49 h
after treatment with 100 µ M of the monofunctional ZD2767D
analogue. Unlike the bifunctional alkylating compounds, where
levels of apoptosis increased with time, the level of monofunc-
tional ZD2767D analogue-induced apoptosis peaked in all three
assays at 25 or 49 h and remained stable for the remainder of the
experiment. 
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Figure 3 Time course of apoptosis induction in LoVo colorectal tumour cells
after a 1-h exposure to ZD2767P + CPG2. Apoptosis was determined after a
1-h exposure to 0.01, 0.1, 1 or 10 µ M ZD2767P + 1 unit/ml CPG2 using (A)
Hoechst 33258 DNA morphology staining, (B) Annexin V-propidium iodide
dual staining and (C) TUNEL. Each bar represents the mean ± s.d. of n = 3
experiments performed as described in Materials and Methods 
Figure 4 Time course of apoptosis induction in LoVo colorectal tumour cells
after a 1-h exposure to chlorambucil. Apoptosis was determined after a 1-h
exposure to 1, 10, 100 or 1000 µ M chlorambucil using (A) Hoechst 33258
DNA morphology staining, (B) Annexin V-propidium iodide dual staining and
(C) TUNEL. Each bar represents the mean ± s.d. of n = 3 experiments
performed as described in Materials and Methods 
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Qualitative and quantitative differences in the effects of
1000 µ M monofunctional ZD2767D analogue on cells, compared
to lower concentrations, were also detected in each of the apop-
tosis assays. Firstly, no chromatin condensation was seen at any of
the five time points studied following 1000 µ M monofunctional
ZD2767D analogue treatment as analysed by the Hoechst 33258
DNA morphology assay (Figure 5A). Secondly, the Annexin V-PI
assay demonstrated high levels (39%) of An V +ve / PI –ve
staining at 1 hour suggesting rapid induction of membrane asym-
metry. However, by 25 h the level of An V +ve / PI –ve staining
had decreased to 2%, a level which was below that in control cells
(6%), following which the Annexin V staining increased in line
with that seen in the control cells. Thirdly, the TUNEL assay also
showed detectable levels of DNA labeling (13%) at 1 h, and by 
25 h the number of cells considered to be above the apoptotic
threshold was 100%. 
The results for the induction of apoptosis by the 1000 µ M
monofunctional ZD2767D analogue varied depending on the
apoptosis assay. When visualized under a light microscope, the
cells were found to have decreased in size and to be firmly fixed to
the plastic of the tissue culture flask. Removal of the cells was not
facilitated by trypsinization but required mechanical force,
suggesting that the cells had undergone drug-induced membrane
changes which caused a fixation-like attachment to the tissue
culture flask. 
Following treatment with 1000 µ M monofunctional ZD2767D
analogue Hoechst 33258 DNA morphology staining showed no
chromatin condensation at any of the time points measured, and a
level lower than in control cells at 49, 73 and 97 h (Figure 5A).
Visualization of the 1000 µ M monofunctional ZD2767D analogue
treated cells showed the nuclei to be smaller than control nuclei
with a homogenous staining pattern and no intra-nuclear structure.
In the annexin V-PI assay the cells were largely detected as being
apoptotic or late apoptotic/necrotic 1 h after treatment, but by 25 h
there was a reduction in the number of apoptotic cells to below
control levels (Figure 5B). Analysis of the cell population from 
25 h onwards demonstrated that all the cells were late
apoptotic/necrotic (Figure 5B). The TUNEL assay also demon-
strated increased labeling of DNA with FITC-dUTP at 1 h, and by
25 h after treatment with 1000 µ M monofunctional ZD2767D
analogue the TUNEL assay showed 100% of the cells to be posi-
tively labelled for apoptosis (Figure 5C). Furthermore, the level of
FITC-dUTP incorporated into each cell was far above that seen
with lower drug concentrations, or with ZD2767P + CPG2 or chlo-
rambucil, suggesting a massive amount of DNA fragmentation in
the cells treated with the monofunctional drug. 
DISCUSSION 
As part of the investigations into the mechanisms and determinants
of ZD2767 ADEPT-induced cytotoxicity, the mode and kinetics of
cell death were studied to establish whether ZD2767P + CPG2
produces cell death via similar mechanisms to those of established
nitrogen mustards such as chlorambucil. 
To investigate the mechanism of cell death induced by ZD2767P
+ CPG2, three different apoptosis assays were used, each assay
measuring apoptosis by assessing a distinct and different morpho-
logical characteristic. Chromatin condensation was visualised
using the Hoechst 33258 DNA binding stain, loss of membrane
phospholipid asymmetry and selective permeability were studied
using the flow cytometric annexin V-propidium iodide assay, and
measurement of inter-nucleosomal DNA cleavage fragments by
the flow cytometric TUNEL assay. 
Exposure of LoVo colorectal tumour cells to ZD2767P + CPG2
for 1 h resulted in a concentration-dependent increase in the level
of apoptosis. All three assays demonstrated the induction of
similar levels of apoptosis which only occurred at ZD2767P +
CPG2 concentrations that induced of growth inhibition (1 and
10 µ M). The level of apoptosis was found to increase with respect
to time at both the 1 and 10 µ M ZD2767P + CPG2 concentrations
in all three assays. 
To establish whether the level and time course of apoptosis
induced by ZD2767P + CPG2 was similar to that produced
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Figure 5 Time course of apoptosis induction in LoVo colorectal tumour 
cells after a 1-h exposure to the monofunctional ZD2767D analogue.
Apoptosis was determined after a 1-h exposure to 1, 10, 100 or 1000 µ M
mono-functional ZD2767 analogue using (A) Hoechst 33258 DNA
morphology staining, (B) Annexin V-propidium iodide dual staining and 
(C) TUNEL. Each bar represents the mean ± s.d. of n = 3 experiments
performed as described in Materials and Methods 
BJOC 01-1947 764-771  20/8/01  3:14 pm  Page 769770 NR Monks et al 
British Journal of Cancer (2001) 85(5), 764–771 © 2001 Cancer Research Campaign
by classical nitrogen mustards, chlorambucil was used as a
comparator. A 1 h exposure to chlorambucil also resulted in a
time-and concentration-dependent increase in the level of apop-
tosis in LoVo colorectal tumour cells. Only 1000 µ M chlorambucil
showed an increase in the level of apoptosis above that in untreated
cells, consistent with the observation that it was only
this concentration that inhibited cell growth. One thousand µ M
chlorambucil produced complete growth inhibition, as did 10 µ M
ZD2767P + CPG2, and the 2 treatments resulted in similar levels
of apoptosis at each time point in all three assays. 
Time and dose-dependency of apoptosis has been demonstrated
previously using the annexin V-propidium iodide dual-staining
assay in the human leukaemia cell line HSB2, following exposure
to the anti-cancer agents cladribine, cytarabine, cisplatin and 5-
fluorouracil (Guchelaar et al, 1998), and in peripheral blood B-
lineage chronic lymphocytic leukaemia cells treated with
chlorambucil (Pepper et al, 1998a). Furthermore, as observed in
the current study, the level of chlorambucil-induced apoptosis in
B-lineage chronic lymphocytic leukaemia cells, measured using
the annexin V-propidium iodide method, was confirmed by, and
correlated closely with, the levels detected by the TUNEL assay
(Pepper et al, 1998b). 
To establish whether the chemical bifunctionality of ZD2767P +
CPG2 influences the mode of cell death and kinetics of apoptosis,
LoVo colorectal tumour cells were treated with the monofunc-
tional ZD2767D analogue for 1 h. As observed with both
ZD2767P + CPG2 and chlorambucil, the induction of apoptosis by
the monofunctional ZD2767D analogue was concentration-
dependent. Apoptosis, above the levels seen in control cells, was
only observed following treatment with 100 µ M monofunctional
ZD2767D analogue, a concentration which induced growth
inhibition. However, in contrast to the results obtained with the
bifunctional agents, the level of apoptosis induced by 100 µ M
monofunctional ZD2767D analogue did not increase with time.
Indeed, the level of apoptosis at 100 µ M remained constant after
25–49 h in all three assays (16–23%), and did not increase to the
levels seen following ZD2767P + CPG2 or chlorambucil exposure
(50–70%). 
The differences in the levels and time-course of apoptosis-
induction by the monofunctional ZD2767D analogue are probably
a direct result of the different type of damage induced by a mono-
functional versus a bifunctional agent. As described previously
(Monks et al, submitted), the monofunctional ZD2767D analogue
leads to the formation of high levels of DNA strand breaks, rather
than the DNA cross-links seen with the bifunctional alkylating
agents ZD2767P + CPG2 and chlorambucil, which presumably
represent different apoptotic signals. 
An explanation for the differences in the time course and level of
apoptosis induced by the mono-functional ZD2767D analogue,
compared to the bifunctional agents ZD2767P + CPG2 and chlo-
rambucil, may be that DNA-DNA interstrand cross-links are only
detected during DNA replication, by inhibiting strand separation at
the replication fork, whilst strand breaks could be detected and
induce apoptosis in all phases of the cell cycle. Comparisons of the
survival and DNA synthesis delay of HeLa cells exposed to mustard
gas and half mustard gas, demonstrated that both compounds
produced dose-dependent DNA synthesis inhibition, although a
higher concentration of the half mustard was needed to produce a
similar effect to the bi-functional mustard (Roberts et al, 1971).
Similarities were observed between the characteristics of cell
death induced by 1000 µ M mono-functional ZD2767D analogue
and necrosis. Consistent with the data for the mon-functional drug,
necrosis does not induce chromatin condensation; however, there is
rapid loss of selective membrane permeability and extensive
nuclear degradation due to the activation of hydrolytic nucleases
and proteases which result in the formation of mono-and oligonu-
cleotides (Umansky, 1996). Consistent with necrotic cell death,
1000 µ M monofunctional ZD2767D analogue induced rapid loss of
selective membrane permeability and extensive levels of early
FITC-dUTP staining. A possible explanation for the extensive
FITC-dUTP labelling in the TUNEL assay is that high levels of
DNA degradation occurred, either due to the extensive non-specific
(random) DNA cleavage which occurs during necrosis (Fernandes
and Cotter, 1994; Lennon et al, 1991) or to the high levels of DNA
strand breaks produced directly by the mono-functional ZD2767D
analogue (Monks et al, submitted). Either of these processes could
have resulted in the high levels of FITC-dUTP labelling seen in the
TUNEL assay. Differences in the mode of cell death has previously
been demonstrated in HL60 cells exposed to numerous anti-cancer
agents, including chlorambucil (Lennon et al, 1991), where it was
shown that low drug concentrations induced apoptosis (detected by
chromatin condensation), whilst higher levels induced necrosis
(shown by loss of membrane integrity). These latter results demon-
strate that an alkylating agent can induce cell death by different
modes and are consistent with the hypothesis that at 1000 µ M the
monofunctional ZD2767D analogue induced cell death by necrosis,
or a mixture of necrosis and apoptosis, whereas apoptosis was the
predominant mode of cell death at 100 µ M. In the context of clin-
ical studies with ZD2767 ADEPT, given the potency of ZD2767P +
CPG2, it is extremely unlikely that concentrations of mono-
functional alkylating agents will be generated that are able to
induce necrosis, and apoptosis is likely to be the sole mechanism of
cell killing in patients. 
In summary, the studies presented here have demonstrated that
ZD2767P + CPG2 induces apoptosis in a time and concentration
dependent manner, similar to that of the classical bifunctional
alkylating agent chlorambucil. Apoptosis only exceeded levels in
control cells at drug concentrations which produced growth inhibi-
tion, with cytostatic concentrations of chlorambucil and ZD2767P
+ CPG2 giving rise to similar levels of apoptosis. Time and
concentration dependent induction of apoptosis was also seen
following exposure to growth inhibitory concentrations of the
monofunctional ZD2767D analogue, although the level and time
course of induction was different to that produced by the bifunc-
tional agents. The differences between the kinetics of apoptosis
and the modes of cell death induced by the bifunctional alkylating
agents (ZD2767P + CPG2 and chlorambucil) and the monofunc-
tional ZD2767D analogue, are consistent with the different types
of DNA lesion produced by the agents. 
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